A Global Study to Assess the Effects of MEDI4736 Following Concurrent Chemoradiation in Patients With Stage III Unresectable Non-Small Cell Lung Cancer
Public ClinicalTrials.gov record NCT02125461. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase III, Randomised, Double-blind, Placebo-controlled, Multi-centre, International Study of MEDI4736 as Sequential Therapy in Patients With Locally Advanced, Unresectable Non-Small Cell Lung Cancer (Stage III) Who Have Not Progressed Following Definitive, Platinum-based, Concurrent Chemoradiation Therapy (PACIFIC)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
A Global Study to Assess the Effects of MEDI4736 following concurrent chemoradiation in Patients with Stage III Unresectable Non-Small Cell Lung Cancer.
Study identification
- NCT ID
- NCT02125461
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 713 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 130 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 6, 2014
- Primary completion
- Feb 12, 2017
- Completion
- Aug 23, 2023
- Last update posted
- Oct 9, 2023
2014 – 2023
United States locations
- U.S. sites
- 60
- U.S. states
- 26
- U.S. cities
- 56
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Chandler | Arizona | 85224 | — |
| Research Site | Goodyear | Arizona | 85338 | — |
| Research Site | Jonesboro | Arkansas | 72405 | — |
| Research Site | Springdale | Arkansas | 72762 | — |
| Research Site | Fullerton | California | 92835 | — |
| Research Site | Los Angeles | California | 90095 | — |
| Research Site | Oxnard | California | 93030 | — |
| Research Site | Sacramento | California | 95816 | — |
| Research Site | San Diego | California | 92123 | — |
| Research Site | Santa Rosa | California | 95403 | — |
| Research Site | Norwich | Connecticut | 06360 | — |
| Research Site | Washington D.C. | District of Columbia | 20007 | — |
| Research Site | Fort Myers | Florida | 33901 | — |
| Research Site | Jacksonville | Florida | 32207 | — |
| Research Site | Miami Beach | Florida | 33140 | — |
| Research Site | Orlando | Florida | 32804 | — |
| Research Site | Port Saint Lucie | Florida | 34952 | — |
| Research Site | St. Petersburg | Florida | 33705 | — |
| Research Site | Tampa | Florida | 33612 | — |
| Research Site | Atlanta | Georgia | 30318 | — |
| Research Site | Atlanta | Georgia | 30322 | — |
| Research Site | Fort Gordon | Georgia | 30905 | — |
| Research Site | Lawrenceville | Georgia | 30046 | — |
| Research Site | Marietta | Georgia | 30060 | — |
| Research Site | Waterloo | Iowa | 50701 | — |
| Research Site | Topeka | Kansas | 66606 | — |
| Research Site | Hazard | Kentucky | 41701 | — |
| Research Site | Baltimore | Maryland | 21287 | — |
| Research Site | Rockville | Maryland | 20850 | — |
| Research Site | Rosedale | Maryland | 21237 | — |
| Research Site | Salisbury | Maryland | 21801 | — |
| Research Site | Towson | Maryland | 21204 | — |
| Research Site | Boston | Massachusetts | 02215 | — |
| Research Site | Lansing | Michigan | 48910 | — |
| Research Site | Minneapolis | Minnesota | 55426 | — |
| Research Site | St Louis | Missouri | 63110 | — |
| Research Site | Lincoln | Nebraska | 68510 | — |
| Research Site | Hackensack | New Jersey | 07601 | — |
| Research Site | Lake Success | New York | 11041 | — |
| Research Site | The Bronx | New York | 10461 | — |
| Research Site | Burlington | North Carolina | 27215 | — |
| Research Site | Charlotte | North Carolina | 28204 | — |
| Research Site | Pinehurst | North Carolina | 28374 | — |
| Research Site | Winston-Salem | North Carolina | 27103 | — |
| Research Site | Blue Ash | Ohio | 45242 | — |
| Research Site | Easley | South Carolina | 29640 | — |
| Research Site | Chattanooga | Tennessee | 37404 | — |
| Research Site | Nashville | Tennessee | 37203 | — |
| Research Site | Nashville | Tennessee | 37232-8805 | — |
| Research Site | Austin | Texas | 78731 | — |
| Research Site | Dallas | Texas | 75231 | — |
| Research Site | Dallas | Texas | 75246 | — |
| Research Site | Fort Worth | Texas | 76104 | — |
| Research Site | Houston | Texas | 77030 | — |
| Research Site | Tyler | Texas | 75702 | — |
| Research Site | Salt Lake City | Utah | 84106 | — |
| Research Site | Fairfax | Virginia | 22031 | — |
| Research Site | Spokane | Washington | 99208 | — |
| Research Site | Spokane | Washington | 99218 | — |
| Research Site | Vancouver | Washington | 98684 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 176 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02125461, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 9, 2023 · Synced Sep 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02125461 live on ClinicalTrials.gov.